Evercore ISI has updated its outlook on CVS Health (NYSE:CVS) shares, raising the price target from $60.00 to $65.00 while maintaining an Outperform rating. The adjustment comes in anticipation of ...

Evercore ISI raised the firm’s price target on CVS Health (CVS) to $65 from $60 and keeps an Outperform rating on the shares. Given 2025 will ...

Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ETCompany ParticipantsKaty Haber - Managing Director, Investor ...

Fintel reports that on January 7, 2025, Evercore ISI Group upgraded ... 48,000 employees globally, Cardinal Health is essential to care. Fintel is one of the most comprehensive investing research ...

Evercore ISI upgraded Cardinal Health (CAH) to Outperform from In Line with an unchanged price target of $140. The firm sees the company’s fiscal 2025 pharma guidance as conservative with upside ...

Evercore ISI analyst Elizabeth Anderson ... high-value care in both in-person and virtual care settings. Read More on PRVA: Privia Health Group NewsMORE Related Stocks Indices Commodities ...

Evercore made slight adjustments to its estimates, reducing the Q4 2024 EPS forecast to $2.54 from $2.56 and the full-year 2025 estimate to $8.77 from $8.84, primarily due to softer international ...

On Tuesday, Evercore ISI raised its rating on Cardinal Health (NYSE:CAH) shares from In Line to Outperform, maintaining a price target of $140.00. The company, currently trading near its 52-week high ...